Although the estimated prevalence of BWS in patients with ACC is very low and restricted to the childhood [5, 7], IGF2 has been reported to be over-expressed in about 70–90% of sporadic ACCs as compared to normal adrenals or benign adrenocortical tumors [8–17]. Here, IGF2 is linked to adrenal cortex carcinoma.